Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA.
Am J Kidney Dis. 2010 Mar;55(3):549-57. doi: 10.1053/j.ajkd.2009.11.014. Epub 2010 Feb 8.
Characteristics of patients with chronic kidney disease who survive to end-stage renal disease may change over time, affecting subsequent outcomes and costs. We examined trends in older incident hemodialysis patient characteristics and analyzed first-year post-dialysis therapy initiation medical costs.
Retrospective cohort study.
SETTING & PARTICIPANTS: All US incident hemodialysis patients aged > or =67 years at dialysis therapy initiation from January 1, 1995, to December 31, 2005, with Medicare Part A and Part B in the prior 2 years.
Year of dialysis therapy initiation.
Changes in patient characteristics and first-year costs.
Mean and median values for continuous variables and percentages of categorical variables; first-year total medical costs measured per person per year. Observed costs were adjusted using Medicare Price Indices and patient case-mix.
Median age at dialysis therapy initiation increased from 74.9 to 77.0 years from 1995 (n = 19,044) to 2005 (n = 31,796; P < 0.001). Diabetes prevalence increased from 54.2% to 64.1% (P < 0.001). Median estimated glomerular filtration rate increased from 8.0 to 11.2 mL/min/1.73 m(2), and median hemoglobin level increased from 9.4 to 10.2 g/dL. Obesity increased from 8.9% to 22.9% (P < 0.001). First-year observed costs increased by 37.9%; however, inflation-adjusted and case-mix-inflation-adjusted costs were stable. Important adjusters for costs are inability to ambulate/transfer, baseline serum albumin level, primary end-stage renal disease cause, comorbid peripheral vascular disease, and baseline hospital days.
Population aged > or =67 years at dialysis therapy initiation and results may not generalize to the overall hemodialysis population.
From 1995 to 2005, incident hemodialysis patients aged > or =67 years became older, sicker, and more obese with significantly increased estimated glomerular filtration rates and hemoglobin levels at dialysis therapy initiation. Increased first-year post-dialysis therapy initiation costs became stable over time after adjustment for price inflation; case-mix-inflation-adjusted costs remained constant, possibly because of mixed changes in patient characteristics.
患有慢性肾病并存活至终末期肾病的患者的特征可能会随时间而改变,从而影响后续的结果和成本。我们研究了老年血液透析患者特征的变化趋势,并分析了透析后第一年开始治疗的医疗成本。
回顾性队列研究。
所有在美国,1995 年 1 月 1 日至 2005 年 12 月 31 日期间开始透析治疗时年龄大于或等于 67 岁的新发生的血液透析患者,且在开始透析前的 2 年内均有 Medicare Part A 和 Medicare Part B。
透析治疗开始的年份。
患者特征和第一年成本的变化。
连续变量的平均值和中位数,分类变量的百分比;以每人每年为单位测量第一年的总医疗费用。使用 Medicare 价格指数和患者病例组合对观察到的成本进行调整。
1995 年(n=19044)和 2005 年(n=31796)开始透析治疗的患者年龄中位数从 74.9 岁增加到 77.0 岁(P<0.001)。糖尿病患病率从 54.2%增加到 64.1%(P<0.001)。估计肾小球滤过率中位数从 8.0 增加到 11.2mL/min/1.73m(2),血红蛋白中位数从 9.4 增加到 10.2g/dL。肥胖的比例从 8.9%增加到 22.9%(P<0.001)。第一年观察到的成本增加了 37.9%;然而,经过通胀调整和病例组合通胀调整后,成本保持稳定。成本的重要调整因素包括无法行走/转移、基线血清白蛋白水平、主要终末期肾病病因、合并的外周血管疾病和基线住院天数。
人口年龄大于或等于 67 岁开始透析治疗,结果可能不适用于整个血液透析人群。
从 1995 年到 2005 年,年龄大于或等于 67 岁的新发生血液透析患者年龄更大、病情更严重、更肥胖,透析开始时的估计肾小球滤过率和血红蛋白水平显著升高。经过价格通胀调整后,透析后第一年开始治疗的成本增加趋于稳定;病例组合通胀调整后的成本保持不变,这可能是由于患者特征的混合变化所致。